Ajit Shetty

reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium.

Cilag GmbH International conducts and coordinates international business in the pharmaceutical, chemical, consumer goods, medical products, and food products sectors. It also engages in the management of the corresponding research and development, particularly with reference to trading with products in these sectors. The company was founded in 1984 and is headquartered in Zug, Switzerland.

Optimal Strategix Group, Inc. provides marketing strategy consulting, analytics, and customized research services. It offers litigation support services. The company was founded by R. Sukumar in 2008 and is headquartered in Newtown, PA.

GS1 AISBL is a Belgian company that provides supply chain standards to communicate with industry's customers, partners, and suppliers. The non-profit company is based in Brussels, BE, and has a global presence of subsidiaries in several regions. The company offers GS1 barcodes/GTINs that are necessary for most online and traditional retailers. The company optimizes the supply chain and life cycle management for Technical Industries. The company provides tools to calculate the check characters pair for the GMN and validate the structure and composition of the basic UDI-DI used for regulated healthcare medical devices. GS1 ID Keys give companies efficient ways to access information about items in their supply chains and share this information with trading partners. The company was founded in 1971, and the CEOs are Kathryn E. Wengel and Renaud de Barbuat.

Rejuvenate Biomed is a clinical-stage platform and Belgian pipeline company founded in 2017 by Ann Belià « n. The company is committed to discovering and developing innovative combination drugs that can safely delay the onset of various age-related diseases. Rejuvenate Biomed has developed two proprietary drug discovery platforms, in silico combinagetm and in vivo celegagetm, to efficiently screen molecule libraries across a wide spectrum of age-related pathways. RJX-01, one of their drugs, is ready for a phase 2b clinical trial in sarcopenia, a musculoskeletal disease. The company is based on the Health Campus Limburg in Heusden-Zolder, BE. Ann Beliën has been the CEO since incorporation.

Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China.